Versions Compared

Old Version 21

changes.mady.by.user Rachel Eastwood

Saved on

compared with

New Version 22

changes.mady.by.user Katia Zilber

Saved on

Key

  • This line was added.
  • This line was removed.
  • Formatting was changed.
 

SHRINE National Pilot was an implementation of SHRINE technology in order to create a demonstration network that included selected academic health centers from across the United States. The demonstration focused on discovering co-morbidities related to the primary diagnoses of autism and diabetes. Each participating site secured regulatory and policy approval and then designated a limited group of researchers who tested the network and performed the research during the demonstration period.

Pilot members included The Clinical Translational Science Institute - University of Washington,Cincinnati Children's Hospital Medical Center, The University of Texas Health Science Center at Houston, Wake Forest Baptist Medical Center, Michigan Institute for Clinical & Health Research, Boston Children's Hospital, Partners Healthcare, and University of California, San Francisco.

View the SHRINE National Pilot poster  presented at AMIA CRI 2013.

SHRINE Ontology for National Demo:

...

  • The patients must be diagnosed with either Autism Spectrum Disorders (ICD9 299.) or Diabetes Mellitus (ICD9 250.) at least once between 6/01/09 – 5/31/11.
  • Demographics include only age, gender, race and ethnicity.
  • No Labs and Medications
Additional content coming soon.